Company Overview of Neogenix Oncology, Inc.
Philip M. Arlen M.D.
Chief Executive Officer, President, Chief Medical Officer and Director, Neogenix Oncology, Inc.
|Age||Total Calculated Compensation||This person is connected to 1 Board Members in 1 different organizations across 2 different industries.|
See Board Relationships
Dr. Philip M. Arlen, M.D. serves as the Chief Executive Officer of Precision Biologics, Inc. Dr. Arlen has been the Chief Executive Officer of Neogenix Oncology Inc., since March 2010 and its President and Chief Medical Officer since September 28, 2008. He focused on the clinical development program for Neogenix Oncology's novel monoclonal antibody, NPC-1C, which was intended for the treatment of pancreatic cancer. In addition, he plays an integral role in the R&D effort ...
445 Northern BoulevardPhone: 516-482-1200
Great Neck, New York 11021
Board Members Memberships
Chief Executive Officer, President, Chief Medical Officer and Director
Medical College Of Georgia
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|There is no Competitor Compensation data available.|
Sponsored Financial Commentaries
Request Profile Update
Only a company representative may request an update for the company profile. Documentation will be required.
Please enter your information in the following field(s):